Autoantibodies to annexins: a diagnostic marker for cutaneous disorders?

[1]  E. Bröcker,et al.  Localization of annexins in normal and diseased human skin. , 1993, Journal of dermatological science.

[2]  E. Bröcker,et al.  Inhibition of human skin phospholipase A2 by "lipocortins" is an indirect effect of substrate/lipocortin interaction. , 1993, The Journal of investigative dermatology.

[3]  D. Rampton,et al.  Antibodies to human recombinant lipocortin-I in inflammatory bowel disease. , 1993, Clinical science.

[4]  G. Ciliberto,et al.  Anti‐inflammatory actions of an N‐terminal peptide from human lipocortin 1 , 1993, British journal of pharmacology.

[5]  L. Berrino,et al.  Antiflammins suppress the A23187- and arachidonic acid-dependent chloride secretion in rabbit distal colonic mucosa. , 1992, The Journal of pharmacology and experimental therapeutics.

[6]  J. J. Moreno,et al.  Antiflammins. Anti-inflammatory activity and effect on human phospholipase A2. , 1992, Biochemical pharmacology.

[7]  R. Huber,et al.  Crystal and molecular structure of human annexin V after refinement. Implications for structure, membrane binding and ion channel formation of the annexin family of proteins. , 1992, Journal of molecular biology.

[8]  J. Römisch,et al.  Annexins I to VI: quantitative determination in different human cell types and in plasma after myocardial infarction , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[9]  J. Römisch,et al.  Detection of human anti-annexin autoantibodies by enzyme immunoassays. , 1992, Journal of immunoassay.

[10]  K. Chung,et al.  Circulating autoantibodies to recombinant lipocortin-1 in asthma. , 1991, Respiratory medicine.

[11]  F. Russo-Marie.  Lipocortins: an update. , 1991, Prostaglandins, leukotrienes, and essential fatty acids.

[12]  R. Huber,et al.  The calcium binding sites in human annexin V by crystal structure analysis at 2.0 A resolution Implications for membrane binding and calcium channel activity , 1990, FEBS letters.

[13]  J. McGrath,et al.  The presence of autoantibody to recombinant lipocortin‐I in patients with psoriasis and psoriatic arthritis , 1990, The British journal of dermatology.

[14]  D. Schlaepfer,et al.  Expression of annexins as a function of cellular growth state , 1990, The Journal of cell biology.

[15]  R. Flower,et al.  Anti-inflammatory lipocortin 1 production by peripheral blood leucocytes in response to hydrocortisone , 1990, The Lancet.

[16]  J. Pfeilschifter,et al.  ‘Antiflammins’: Two nonapeptide fragments of uteroglobin and lipocortin I have no phospholipase A2 ‐inhibitory and anti‐inflammatory activity , 1990, FEBS letters.

[17]  T. Lee,et al.  Bronchial asthma is not associated with auto‐antibodies to lipocortin‐1 , 1990, Clinical and Experimental Allergy.

[18]  J. Ernst,et al.  Characterization of Ca2(+)-dependent phospholipid binding, vesicle aggregation and membrane fusion by annexins. , 1990, The Biochemical journal.

[19]  J. Römisch,et al.  Purification and characterization of six annexins from human placenta. , 1990, Biological chemistry Hoppe-Seyler.

[20]  R. Flower,et al.  Autoantibodies to recombinant lipocortin-1 in rheumatoid arthritis and systemic lupus erythematosus. , 1989, Annals of the rheumatic diseases.

[21]  F. Russo-Marie,et al.  A purified lipocortin shares the anti‐inflammatory effect of glucocorticosteroids in vivo in mice , 1989, British journal of pharmacology.

[22]  R. Flower,et al.  Human recombinant lipocortin 1 has acute local anti-inflammatory properties in the rat paw edema test. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[23]  J. van Binsbergen,et al.  Synthetic peptide from lipocortin I has no phospholipase A2 inhibitory activity , 1989, FEBS letters.

[24]  M. Geisow,et al.  The annexin family of calcium-binding proteins. Review article. , 1989, Cell calcium.

[25]  R. Flower.  Lipocortin and the mechanism of action of the glucocorticoids , 1988, British journal of pharmacology.

[26]  R. Flower,et al.  Recombinant human lipocortin 1 inhibits thromboxane release from guinea-pig isolated perfused lung , 1987, Nature.

[27]  H. van den Bosch,et al.  Lipocortin inhibition of extracellular and intracellular phospholipases A2 is substrate concentration dependent , 1987, FEBS letters.

[28]  H. Hemker,et al.  Isolation and partial purification of a novel anticoagulant from arteries of human umbilical cord. , 1985, European journal of biochemistry.

[29]  M. Nirenberg,et al.  Presence of autoantibody for phospholipase inhibitory protein, lipomodulin, in patients with rheumatic diseases. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[30]  G. J. Blackwell,et al.  Macrocortin: a polypeptide causing the anti-phospholipase effect of glucocorticoids , 1980, Nature.

[31]  F. Hirata,et al.  A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. , 1980, Proceedings of the National Academy of Sciences of the United States of America.